Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Open and closed-loop control systems01:17

Open and closed-loop control systems

Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal and...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tubed or tubeless insulin pumps? A retrospective real-world analysis of national French health data.

BMJ open diabetes research & care·2026
Same author

How PNIPAM Microgel Architecture Controls Pickering Foam Formation.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Pickering emulsions stabilized by microgels: Three regimes of surface coverage.

Journal of colloid and interface science·2025
Same author

Inter cross-linking microgels by superchaotropic nano-ions at interface: Controlled stabilization of emulsions.

Journal of colloid and interface science·2025
Same author

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.

The lancet. Diabetes & endocrinology·2024
Same author

Study of the Interactions between Simple Coacervates and Chemicals for Water Depollution by Self-coacervation.

Langmuir : the ACS journal of surfaces and colloids·2024

Related Experiment Video

Updated: Jul 1, 2026

Three-dimensional Printing of Thermoplastic Materials to Create Automated Syringe Pumps with Feedback Control for Microfluidic Applications
09:08

Three-dimensional Printing of Thermoplastic Materials to Create Automated Syringe Pumps with Feedback Control for Microfluidic Applications

Published on: August 30, 2018

Chemically controlled closed-loop insulin delivery.

Valérie Ravaine1, Christophe Ancla, Bogdan Catargi

  • 1Université Bordeaux, Institut des Sciences Moléculaires, ENSCPB, Pessac Cedex, France. ravaine@enscpb.fr

Journal of Controlled Release : Official Journal of the Controlled Release Society
|September 11, 2008
PubMed
Summary

Researchers are developing artificial closed-loop systems for diabetes management, mimicking pancreas function for automatic glucose control. These systems use glucose-responsive materials or modified insulin for improved treatment.

More Related Videos

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
11:49

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level

Published on: November 17, 2013

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

Related Experiment Videos

Last Updated: Jul 1, 2026

Three-dimensional Printing of Thermoplastic Materials to Create Automated Syringe Pumps with Feedback Control for Microfluidic Applications
09:08

Three-dimensional Printing of Thermoplastic Materials to Create Automated Syringe Pumps with Feedback Control for Microfluidic Applications

Published on: August 30, 2018

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
11:49

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level

Published on: November 17, 2013

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
07:55

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Endocrinology

Background:

  • Diabetes mellitus requires continuous glucose monitoring and insulin administration.
  • Current treatments like transplantation are limited; artificial pancreas systems offer a promising alternative.
  • Hyperglycemia complications necessitate advanced, automated diabetes management solutions.

Purpose of the Study:

  • To explore novel artificial closed-loop systems for automated diabetes treatment.
  • To investigate glucose-responsive materials and modified insulin for precise insulin delivery.
  • To advance biocompatibility, selectivity, and ease of administration for in vivo diabetes care.

Main Methods:

  • Development of glucose-responsive polymeric hydrogels for insulin delivery.
  • Modification of insulin with glucose-sensitive functional groups to modulate activity.
  • Evaluation of system performance for biocompatibility, pharmacokinetics, and administration.

Main Results:

  • Progress in developing glucose-responsive hydrogels that adapt insulin release to glucose levels.
  • Advancements in chemically modified insulin for triggered activity based on glucose concentration.
  • Demonstrated improvements in biocompatibility, selectivity, and ease of administration for potential in vivo use.

Conclusions:

  • Chemically controlled closed-loop insulin delivery systems show significant promise for diabetes treatment.
  • These systems offer a potential alternative to current diabetes management strategies.
  • Further research is needed to overcome remaining challenges for clinical application.